Kidney Research and Clinical Practice

Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients: Hee-Yeon Jung, Yu Jin Seo, Deokbi Hwang et al.; Kidney Res Clin Pract. 2025;44(1):200-209. Published online October 24, 2024; DOI: https://doi.org/10.23876/j.krcp.23.274
Web of Science 3 Cited By 4; Full text PubReader ePub PDF Supplementary Material

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy: Sang Youb Han, Chan-Young Jung, Sang Ho Lee et al.; Kidney Res Clin Pract. 2022;41(4):452-461. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.146
Web of Science 11 Cited By 10; Full text PubReader ePub PDF Supplementary Material

The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients: Mohamed S. AbdElhalim, Ahmed S. Kenawy, Heba H. El Demellawy et al.; Kidney Res Clin Pract. 2020;39(4):479-486. Published online November 20, 2020; DOI: https://doi.org/10.23876/j.krcp.20.059
Web of Science 4 Cited By 2; Full text PubReader PDF

Efficacy of Mycophenolate Mofetil in the Treatment of Refractory Membranous Nephropathy and Focal Segmental Glomerulosclerosis: Mihyun Jang, M.D. Eunah Hwang, M.D. Sangmok Yeou, M.D. Choonghwan Kwak, M.D. Seungyeup Han, M.D. Sungbae Park, M.D. Hyunchul Kim, M.D. and Misun Choe, M.D.; Korean J Nephrol. 2010;29(6):708-715.; PDF

A Case of Concurrent Pneumocystis carinii Pneumonia and CMV Pneumonia in a SLE Patient with Mycophenolate Mofetil: Eun Hee Jang, M.D. and Min Ok Kim, M.D.; Korean J Nephrol. 2008;27(4):502-507.; PDF

'Rescue Therapy' with Mycophenolate Mofetil in Non-transplant Renal Disease Patients Experienced Conventional Immunosuppressive Treatments : Clinical Observation: Byeong Yun Yang, M.D., Jin Kang, M.D., Sang Heon Song, M.D. Dong Won Lee, M.D. and Ihm Soo Kwak, M.D.; Korean J Nephrol. 2008;27(1):110-116.; PDF

Original Article : Mycophenolate Mofetil or Intravenous Cyclophosphamide for the Initial Induction Therapy of Lupus Nephritis; Clinical Observations: Yong Kyun Kim, M.D. Yeon Sil Do, M.D. So Yeon Choi, M.D. Eun Hee Jang, M.D.Jung Eun Lee, M.D. Hoon-Suk Cha, M.D. Wooseong Huh, M.D. Dae Joong Kim, M.D.Ha-Young Oh, M.D. Ghee Young Kwon, M.D. Eun-Mi Koh, M.D. and Yoon Goo Kim, M.D.; Korean J Nephrol. 2007;26(2):160-166.; PDF

25,491	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
8,508	Management of high-flow arteriovenous access
4,223	Safety and efficacy of glucagon-like peptide 1 receptor agonists in solid organ transplant recipients with diabetes mellitus: a systematic review and meta-analysis
6,826	Clinical guidelines for the diagnosis, evaluation, and management of hypertension for Korean children and adolescents: the Korean Working Group of Pediatric Hypertension
7,554	Precision medicine for focal segmental glomerulosclerosis

Cited By 12	Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Cited By 11	Status and trends in epidemiologic characteristics of diabetic end-stage renal disease: an analysis of the 2021 Korean Renal Data System
Cited By 11	School urinary screening program in Japan: history, outcomes, perspectives
Cited By 11	Artificial intelligence and machine learning’s role in sepsis-associated acute kidney injury
Cited By 11	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions

Search